Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EaglePicher Pharmaceutical Services

EaglePicher Pharmaceutical Services
1985 FOUNDED
M&A STATUS
51-60 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
2 INVESTMENTS
Description

Manufacturer of anti-cancer active pharmaceutical ingredients and high-potency compounds. The company's services include early-to-stage product development, potent compound manufacturing, radiolabeling, analytical services, and regulatory support services. It serves government, research, radiochemical, and API production syntheses sectors.

Formerly Known As
Midwest Research Institute
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • 13605 West 96th Terrace
  • Lenexa, KS 66215
  • United States

+1 (913) 000-0000

EaglePicher Pharmaceutical Services Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore EaglePicher Pharmaceutical Services‘s full profile, request access.

Request full access to PitchBook

EaglePicher Pharmaceutical Services Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 17-Nov-2008 00000 00000 00 000 Diagnostic Equipment
Evogen 04-Apr-2002 Early Stage VC 00.00 Diagnostic Equipment
To view this company’s complete investment and acquisition history, request access »

EaglePicher Pharmaceutical Services Executive Team (2)

Name Title Board
Seat
Contact
Info
Scott Parker Director, Business Development & Sales Manager

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »